Arizona State Retirement System’s Aclaris Therapeutics ACRS Stock Holding History

Arizona State Retirement System’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,853	Closed	-$14.5K	–	2125
2023 Q4	$14.5K	Sell	13,853 -234	-2%	-$714	﹤0.01%	2144
2023 Q3	$96.5K	Buy	14,087 +37	+0.3%	+$316	﹤0.01%	2081
2023 Q2	$146K	Buy	14,050 +525	+4%	+$4.75K	﹤0.01%	2033
2023 Q1	$109K	Buy	13,525 +356	+3%	+$4.52K	﹤0.01%	2099
2022 Q4	$207K	Buy	13,169 +504	+4%	+$8.11K	﹤0.01%	1885
2022 Q3	$199K	Buy	12,665 +1,050	+9%	+$16.5K	﹤0.01%	1890
2022 Q2	$162K	Sell	11,615 -798	-6%	-$11.2K	﹤0.01%	2004
2022 Q1	$214K	Buy	12,413 +56	+0.5%	+$764	﹤0.01%	1982
2021 Q4	$180K	Buy	12,357 +273	+2%	+$4.14K	﹤0.01%	2111
2021 Q3	$218K	Buy	+12,084	New	+$194K	﹤0.01%	2031

Other funds holding ACRS

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arizona State Retirement System's ACRS Position: Q1 2024 in Review

Arizona State Retirement System sold out of Aclaris Therapeutics (ACRS) in Q1 2024, closing a stake of 13,853 shares — an estimated $14.5K sold.

Arizona State Retirement System first reported a position in ACRS in Q3 2021 and held it in 10 quarters. The position peaked at $218K in Q3 2021. 98 funds tracked by Wall St. Rank hold ACRS as of Q1 2024.

Arizona State Retirement System reported no remaining Aclaris Therapeutics position as of Q1 2024 after selling out during the quarter.
Arizona State Retirement System sold 13,853 Aclaris Therapeutics shares in Q1 2024, an estimated $14.5K.
Arizona State Retirement System first reported a position in Aclaris Therapeutics in Q3 2021 and held it in 10 quarters.
Arizona State Retirement System's Aclaris Therapeutics position peaked at $218K in Q3 2021.
98 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2024.

Based on Arizona State Retirement System's 13F filing for Q1 2024, filed 7 May 2024.